Royal Bank of Canada »

Mineralys Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $54k 6.4k 8.40
2023-09-30 $21k 2.2k 9.58
2023-06-30 $22k 1.3k 16.86

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
UnitedHealth (UNH)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Mineralys Therapeutics

Samsara BioCapital
RA Capital Management
Braidwell
Sr One Capital Management
BlackRock
Laurion Capital Management
Vanguard Group
Sphera Funds Management
Franklin Resources
Blue Owl Capital Holdings
Millennium Management
Point72 Asset Management
Charles Schwab Investment Management
Citadel Advisors
Two Sigma Investments

View all funds holding Mineralys Therapeutics